Finance

Lists
VTR:NYSE
Ventas Inc
84,31 USD
+0,56%
(+0,47) 1D
14-окт., 16:02:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTR...
Open
84,18 USD
High
85,40 USD
Low
83,26 USD
Mkt. cap
43,25 млд
Avg. vol.
3,93 млн
Volume
2,57 млн
Dividend
2,42%
Quarterly dividend
0,51 USD
Ex-dividend date
2026-ж., 30-сен.
P/E ratio
154,68
52-wk high
101,60 USD
52-wk low
67,80 USD
EPS
0,55 USD
Beta
0,71
Shares outstanding
512,95 млн
No. of employees
542
Open
84,18 USD
High
85,40 USD
Low
83,26 USD
Mkt. cap
43,25 млд
Avg. vol.
3,93 млн
Volume
2,57 млн
Dividend
2,42%
Quarterly dividend
0,51 USD
Ex-dividend date
2026-ж., 30-сен.
P/E ratio
154,68
52-wk high
101,60 USD
52-wk low
67,80 USD
EPS
0,55 USD
Beta
0,71
Shares outstanding
512,95 млн
No. of employees
542
News stories
From web sources and news partners
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees542
Founded1983
HeadquartersЧикаго, Иллинойс, Америка Кошмо Штаттары
SectorReal estate investment trust
Analyst ratings
Based on 15 analysts giving stock ratings to VTR in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current 84,31 USD
113,00 USD (+34,03%)
Average
99,00 USD (+17,42%)
Lowest
72,00 USD (-14,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Goldsmith
UBS
Hold
Maintained
90,00 USD
+6,7%
10/13/2026
Richard Hightower
Barclays
Hold
Maintained
91,00 USD
+7,9%
10/13/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
107,00 USD
+26,9%
10/02/2026
James Kammert
Evercore ISI
Buy
Maintained
100,00 USD
+18,6%
09/21/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
112,00 USD
+32,8%
09/16/2026
Joe Dickstein
Jefferies
Buy
Initiated
102,00 USD
+21%
09/15/2026
Michael Mueller
J.P. Morgan
Buy
Maintained
104,00 USD
+23,4%
09/03/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
95,00 USD
+12,7%
09/02/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
104,00 USD
+23,4%
09/01/2026
Michael Carroll
RBC Capital
Buy
Reiterated
99,00 USD
+17,4%
08/14/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
90,00 USD
+6,7%
08/13/2026
Nicholas Joseph
Citi
Buy
Maintained
72,00 USD
-14,6%
08/04/2026
Jeffrey Spector
Bank of America Securities
Buy
Reiterated
113,00 USD
+34%
08/03/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
102,00 USD
+21%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
104,00 USD
+23,4%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
114,00 USD
+35,2%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
94,00 USD
+11,5%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
94,00 USD
+11,5%
06/16/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
100,00 USD
+18,6%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
100,00 USD
+18,6%
05/12/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
95,00 USD
+12,7%
05/07/2026
Marie Ferguson
Argus Research
Buy
Maintained
88,00 USD
+4,4%
02/09/2026
Next call 13 күндөн кийин
27-окт., шейш., 16:00
Fiscal period
Q3 2026
- / 0,11 USD
Revenue / Est. (USD)
- / 1,78 млд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,50 млд
1,55 млд
1,65 млд
1,72 млд
Cost of goods sold
869,92 млн
937,40 млн
1,00 млд
1,04 млд
Cost of revenue
869,92 млн
937,40 млн
1,00 млд
1,04 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40,39 млн
41,01 млн
62,75 млн
46,99 млн
Operating expense
397,56 млн
297,53 млн
416,91 млн
422,70 млн
Total operating expenses
1,27 млд
1,23 млд
1,42 млд
1,47 млд
Operating income
233,98 млн
315,49 млн
226,81 млн
254,70 млн
Other non operating income
-13,37 млн
-4,20 млн
-9,70 млн
-4,45 млн
EBT including unusual items
62,36 млн
71,87 млн
43,11 млн
46,60 млн
EBT excluding unusual items
66,67 млн
164,69 млн
63,47 млн
91,99 млн
Income tax expense
-6,34 млн
-1,12 млн
-15,94 млн
-25,62 млн
Effective tax rate
-10,17%
-1,56%
-36,97%
-54,97%
Other operating expenses
-
-
-
-
Net income
66,05 млн
70,20 млн
55,91 млн
70,57 млн
Net profit margin
4,40%
4,53%
3,39%
4,10%
Earnings per share
0,12
0,13
0,10
0,17
Interest and investment income
4,18 млн
7,88 млн
2,50 млн
1,78 млн
Interest expense
-158,12 млн
-154,47 млн
-156,14 млн
-160,03 млн
Net interest expenses
-153,94 млн
-146,59 млн
-153,64 млн
-158,26 млн
Depreciation and amortization charges
357,17 млн
256,52 млн
354,17 млн
375,71 млн
EBITDA
559,73 млн
659,02 млн
585,75 млн
633,56 млн
Gain or loss from assets sale
-1,28 млн
-3,31 млн
-15,06 млн
-174,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору